Introduction
Chronic granulomatous disease (CGD) is one of the congenital immunodeficiencies, which affects intracellular biocidal activity through the impairment of superoxides production. Aspergillus species are a major cause of death in CGD patients and the mortality rate of cerebral aspergillosis in immunocompromised patients is reported to be nearly 100%1). Very few reports to date have described surviving cases of cerebral aspergillosis in CGD, either with an X-linked2)3) or an autosomal recessive trait4). Moreover, no reports could be found on the recurrence of brain abscesses in CGD. Practical information in terms of the management of a given patient and of radiological characterization concerning this devastating condition is, therefore, still limited. A case of X-linked CGD is presented here which survived a recurrence of brain abscess due presumably to Aspergillus.
Case Report
The patient was a 22-year-old male with an X-linked CGD who had multiple episodes of infection at the ages of 13 (pneumonia of unknown etiology) 5), 156), 177) and 19. Aspergillus fumigatus was first isolated from the lung at the age of 15. At that time, an aortography was performed for a diagnostic purpose of pseudosequestration of the lung and this mechanical injury led to a spread of the organism to the brain, and abscess formation6). Following this episode, the patient suffered recurrence of Aspergillus pneumonia at the ages of 17 and 19 which was successfully controlled by treatment with intravenous amphotericin B (Am B). Over the subsequent two years, he remained well with a single episode of a febrile illness which was resolved without extensive therapy.
On February 13, 1998, he came to the hospital complaining of numbness and paresis of the left lower extremity without fever or cough. An MRI of the brain (Fig. 1A) showed a small lesion surrounded by edema in the right parietal lobe which was in exactly the same position as the previous brain abscess6). With a tentative diagnosis of the recurrence of Aspergillus brain abscess, itraconazole (600mg/day, 12mg /kg body weight) was administered orally. Despite the treatment, his illness progressed during a week to Jucksonian seizures which began from clonic movements of the left lower extremity and spread to generalized convulsions. He was admitted to the hospital with a remarkable extension of the lesion (Fig.1B) .
On admission, he showed right convergence palsy with normal adduction, suggesting that the lesion involved an efferent pathway from the Perlia nucleus. A systolic vascular murmur which had been diagnosed as pseudosequestration of the lung6) was consistently audible on his right sternal border suggesting the persistence of the abnormal vasculature over these seven years. Gallium scintigraphy which was taken on the 4th hospital day revealed no abnormal uptake within the lesion. A brain MRI-angiography which was taken on the 18th hospital day delineated an irregular stain in the center of the lesion but no abnormal vessels around the lesion.
White blood cell count was 7,300/mm and CRP was 2.1mg/100ml. Renal function tests and serum 
Discussion
In this patient, although direct evidence could not be obtained, the fact that the exclusive use of Am B was extremely efficacious against the lesion taken together with his previous history strongly indicated that the abscess was due to Aspergillus infection. In general, the mortality rate of cerebral aspergillosis is high. In addition, to my knowledge, there has been no information in the literature concerning the recurrence of brain abscesses in CGD. In this patient, the recurrence was no more severe than the first episode, with an identical radiographical appearance. The negative finding by gallium scintigraphy was rather unexpected due to the fact that the lesion expanded in a relatively short time with a remarkable worsening of the clinical symptoms. In addition, the MRI-angiography showed no vascular invasion. These observations along with no remarkable mass effect in the MRI suggest that the inflammation was well compartmentalized without any blood brain barrier destrcution, which must have been a beneficial factor for this patient.
Recently, a low dose infusion strategy of Am B has been advocated to avoid significant side effects, particularly when a deoxycholate preparation is used. Although this strategy may be available to use in candidiasies8), larger doses of Am B are necessary in many cases of aspergillosis.
In such situations, a longer infusion time, i. e., as long as 24 huors, might be helpful in minimizing the nephrotoxicity of Am B.
The cautious use of Am B over a long infusion time on the basis of the previous experience7) must significantly have contributed to the favorable outcome in this patient. In addition, concerning the nephrotoxicity, an increase in the urinary excretions of electrolytes always preceded a decrease in the serum electrolytes in this patient. Monitoring UexK and UexMg can be performed with a single urine sample. These parameters are highly useful as a simple and early indicator of the nephrotoxicity of Am B.
